Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05793905
Other study ID # UDDS-Pedo-03-2023
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date December 1, 2022
Est. completion date April 3, 2023

Study information

Verified date September 2023
Source Damascus University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In a prospective, randomized clinical trial, triple-blind, split-mouth study, 40 children aged between 7 to 10 with bilateral mandibular primary molars were diagnosed with pulpitis. The test agent was 2% lidocaine with 1:80.000 epinephrine buffered with sodium bicarbonate 8.4% at a ratio of 1/10, as opposed to the control agent, which was non- buffered 2% lidocaine with 1:80,000 epinephrine. The pain will be assessed during inferior alveolar nerve block injection (IANB) and the effectiveness of anesthesia using the subjective Wong-Baker visual analog scale, the objective sound, eye, and motor (SEM) scale, and the physiological pain scale (pulse rate) using a pulse oximeter. The investigator has confirmed the onset of anesthesia after lip tongue-numbing by probing the gingiva until there is no pain. Endo-ice has been used to assess the onset of pulp anesthesia.


Description:

In a prospective, randomized clinical trial and triple-blind, split mouth study, 40 children aged between 7 to 10 with bilateral mandibular primary molars were diagnosed with pulpitis. Random numbers between 1 to 40 were assigned to patients, with some receiving buffered lidocaine at their initial appointment while others received unbuffered lidocaine. The solutions have been switched up for the second session, which has been set for one week later. The test agent was 2% lidocaine with 1:80.000 epinephrine buffered with sodium bicarbonate 8.4% at a ratio of 1/10, as opposed to the control agent, non-buffering 2% lidocaine with 1:80,000 epinephrine. Buffered lidocaine has been freshly prepared by mixing sodium bicarbonate (8.4%) with the anaesthetic solution (lidocaine 2% with epinephrine 1/80.000) in a 1:10 ratio by volume. Two percent benzocaine gel is applied at the injection site for one minute before inferior alveolar nerve block injection (IANB). The investigator has assessed pain during IANB injection using the subjective Wong-Baker visual analogue scale, the objective sound, eye, and motor (SEM) scale, and the physiological pain scale (pulse rate) using a pulse oximeter. After administering the IANB injection, the investigator has confirmed the onset of anaesthesia after lip and tongue numbing by probing the gingiva every 30 seconds until there is no pain. Endo-ice has been used to assess the onset of pulp anaesthesia every 30 seconds. The effectiveness of anaesthesia has been assessed during the preparation of the pulp chamber using subjective, objective, and physiological pain scales. Finally, the numerical data will be statistically analysed, and any statistically significant values will be investigated.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date April 3, 2023
Est. primary completion date March 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 10 Years
Eligibility Inclusion Criteria: - Children who are healthy and free of any underlying conditions that might make local anesthesia impossible to administer. - Children that are not allergic to (lidocaine, adrenaline, or sodium bicarbonate). - Children aged 6-10 years old - Cooperative children on Frankel scale (positive or absolute positive). - children needing bilateral (right and left) endodontic treatment for the mandibular primary molars. - A positive outcome on the cold test for the target tooth. Exclusion Criteria: - Uncooperative children on Frankel's scale (passive or absolute positive). - The presence of a fistula. - The presence of an abscess associated with the target tooth. - The presence of a periapical lesion radially. - Negative response to the cold test. - Children suffering from systemic conditions. - Children who are allergic to (lidocaine, adrenaline, sodium bicarbonate).

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
Buffered lidocaine in inferior alveolar nerve block injection
Buffered Lidocaine 2% with epinephrine 1.80000 mixed with 1.8% sodium bicarbonate in IANB injection in the treatment of bilateral primary mandibular molars
Drug:
lidocaine 2% in inferior alveolar nerve block injection
Lidocaine 2% with epinephrine 1.80000 in IANB injection in the treatment of bilateral primary mandibular molars

Locations

Country Name City State
Syrian Arab Republic College of dentistry. Damascus Al-Mazzeh Saint

Sponsors (1)

Lead Sponsor Collaborator
Damascus University

Country where clinical trial is conducted

Syrian Arab Republic, 

References & Publications (4)

Chopra R, Jindal G, Sachdev V, Sandhu M. Double-Blind Crossover Study to Compare Pain Experience During Inferior Alveolar Nerve Block Administration Using Buffered Two Percent Lidocaine in Children. Pediatr Dent. 2016 Jan-Feb;38(1):25-9. — View Citation

Goodchild JH, Donaldson M. Novel Direct Injection Chairside Buffering Technique for Local Anesthetic Use in Dentistry. Compend Contin Educ Dent. 2019 Jul/Aug;40(7):e1-e10. — View Citation

Kurien RS, Goswami M, Singh S. Comparative evaluation of anesthetic efficacy of warm, buffered and conventional 2% lignocaine for the success of inferior alveolar nerve block (IANB) in mandibular primary molars: A randomized controlled clinical trial. J D — View Citation

Meincken M, Norman C, Arevalo O, Saman DM, Bejarano T. Anesthesia Onset Time and Injection Pain Between Buffered and Unbuffered Lidocaine Used as Local Anesthetic for Dental Care in Children. Pediatr Dent. 2019 Sep 15;41(5):354-357. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Probing the gingiva The onset of anaesthesia at soft tissue will be assessed by probing the gingiva After IANB injection. directly after asking the child about lip, tongue numbing every 30 seconds until there is no pain.
Primary Endo - ice test The investigator will use endo-ice to assess the onset time of pulp anaesthesia. Every 30 seconds after confirmed soft tissues anaesthesia until the absence of pain.
Primary Pulse rate Pulse rate is a physiological pain scale which will be taken through a finger pulse oximeter. A minute before anaesthesia.
Primary Pulse rate Pulse rate is a physiological pain scale, will be taken through a finger pulse oximeter. 20 seconds after the first quarter of the local anaesthesia.
Primary Wong baker faces scale. Wong Baker faces scale is a subjective pain which contains a series of six faces ranging from a happy face at 0 to indicate "no hurt" to a crying face at 10 to indicate "hurts worst" One minute after IANB injection
Primary Sound, eye, motor scale (SEM) Sound, eye, motor scale is an objective pain scale for the assessment of child's behaviour by recording video during anaesthesia Within five seconds from the start of the local anesthetic injection to completion
Secondary Pulse rate Pulse rate is a physiological pain scale which will be taken through a finger pulse oximeter. 20 seconds after opening the pulp chamber
Secondary Wong baker faces scale Wong Baker faces scale is a subjective pain which contains a series of six faces ranging from a happy face at 0 to indicate "no hurt" to a crying face at 10 to indicate "hurts worst" one minute after preparing pulp chamber
Secondary sound, eye, motor scale (SEM) Sound, eye, motor scale is an objective pain scale for the assessment of child's behaviour by recording video during endo access preparation Within five seconds from the start of the local anaesthetic injection to completion
See also
  Status Clinical Trial Phase
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Completed NCT03262857 - Effect of Lidocaine With Magnesium Sulfate on the Success of the Inferior Alveolar Nerve Block Phase 2
Withdrawn NCT03502135 - Efficacy of Tetracaine/Oxymetazoline Nasal Spray for Endodontic Treatment Phase 4
Not yet recruiting NCT02535273 - The Effect of Dexmedetomidine Analgesia and Sedation in Minimally Invasive Spine Surgery Under Local Anesthesia Phase 4
Not yet recruiting NCT05902780 - Can Caudal Dexmedetomidine Provide Effective Analgesia? N/A
Completed NCT04885777 - Topical Lidocaine Anesthesia for Nasopharyngeal Sampling N/A
Recruiting NCT04086394 - PECS Block in Partial Mastectomy for Postoperative Pain Control N/A
Recruiting NCT06129162 - Pain Perception Comparison of Computerized vs Conventional Injection Methods N/A
Completed NCT02922504 - Impact of Music Intervention on Pain Control In First Trimester Surgical Abortion Under Local Anesthesia N/A
Completed NCT00539084 - A Study to Assess the Safety and Efficacy of a Microneedle Device for Local Anesthesia N/A
Completed NCT03176446 - Pain and Anxiety Evaluation in Children Using Different Techniques of Local Anesthesia for Dental Treatment N/A
Completed NCT04947267 - To Compare the Pulpal Oxygen Saturation Level After Administering Mepivacaine With and Without Vasoconstrictor Phase 2
Completed NCT02825225 - A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes N/A
Completed NCT01360749 - Efficacy and Safety of Lambdalina (Lidocaine Cream) Versus Placebo as an Anesthetic for Laser Hair Removal Phase 2
Completed NCT00889642 - Safety and Efficacy Study of an Iontophoretic Patch Containing Lidocaine and Epinephrine for Venipuncture in Healthy Adult Volunteers Phase 2
Active, not recruiting NCT05473819 - Effectiveness of Sodium Bicarbonate Buffered Anaesthetic Solution on Pain During Injection N/A
Completed NCT04653974 - Pain Perception of Needle-free System N/A
Completed NCT02884596 - Success of Inferior Alveolar Nerve Block in Women Taking Selective Serotonin Reuptake Inhibitors
Completed NCT02440347 - Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block Phase 4
Completed NCT02371759 - Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2 Phase 3